Literature DB >> 8739783

Multiple endocrine neoplasia type 1 associated with spinal ependymoma.

H Kato1, I Uchimura, M Morohoshi, K Fujisawa, Y Kobayashi, F Numano, N Goseki, M Endo, A Tamura, C Nagashima.   

Abstract

A 51-year-old man was hospitalized with a gait disturbance and hypoesthesia below the level of his chest. These symptoms were due to a spinal tumor which was surgically resected and identified as an ependymoma. Additionally, the patient had hypercalcemia and a family history of insulinoma. An endocrine evaluation revealed parathyroid hyperplasia and a pancreatic islet cell tumor. Magnetic resonance imaging disclosed a pituitary microadenoma. He was diagnosed with spinal ependymoma and multiple endocrine neoplasia type 1 (MEN 1). A review of the literature revealed that chromosome 11q13 abnormalities have been reported in both ependymoma and MEN 1. We discuss the pathogenesis of these diseases.

Entities:  

Mesh:

Year:  1996        PMID: 8739783     DOI: 10.2169/internalmedicine.35.285

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  12 in total

1.  Intracranial ependymoma associated with multiple endocrine neoplasia type 1.

Authors:  A Al-Salameh; P François; S Giraud; A Calender; A-M Bergemer-Fouquet; L de Calan; P Goudet; P Lecomte
Journal:  J Endocrinol Invest       Date:  2010-02-05       Impact factor: 4.256

Review 2.  Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.

Authors:  Jonathan D Wasserman; Gail E Tomlinson; Harriet Druker; Junne Kamihara; Wendy K Kohlmann; Christian P Kratz; Katherine L Nathanson; Kristian W Pajtler; Andreu Parareda; Surya P Rednam; Lisa J States; Anita Villani; Michael F Walsh; Kristin Zelley; Joshua D Schiffman
Journal:  Clin Cancer Res       Date:  2017-07-01       Impact factor: 12.531

3.  Genetic abnormalities and CNS tumors: report of two cases of ependymoma associated with Klinefelter's Syndrome (KS).

Authors:  M L Garrè; V Capra; E Di Battista; L Giampietri; P Nozza; A Raso; A Pezzolo; A Rossi; C Milanaccio; M Pavanello; A Naselli
Journal:  Childs Nerv Syst       Date:  2006-10-13       Impact factor: 1.475

Review 4.  [Multiple endocrine neoplasia type I].

Authors:  E Koncz; K W Schmid
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

5.  Genetic confirmation that ependymoma can arise as part of multiple endocrine neoplasia type 1 (MEN1) syndrome.

Authors:  Areli K Cuevas-Ocampo; Andrew W Bollen; Benjamin Goode; Kristian W Pajtler; Lukas Chavez; Tanvi Sharma; Sun-Chuan Dai; Michael McDermott; Arie Perry; Andrey Korshunov; David A Solomon
Journal:  Acta Neuropathol       Date:  2017-02-25       Impact factor: 17.088

Review 6.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

7.  Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.

Authors:  S Giraud; C X Zhang; O Serova-Sinilnikova; V Wautot; J Salandre; N Buisson; C Waterlot; C Bauters; N Porchet; J P Aubert; P Emy; G Cadiot; B Delemer; O Chabre; P Niccoli; F Leprat; F Duron; B Emperauger; P Cougard; P Goudet; E Sarfati; J P Riou; S Guichard; M Rodier; A Meyrier; P Caron; M C Vantyghem; M Assayag; J L Peix; M Pugeat; V Rohmer; M Vallotton; G Lenoir; P Gaudray; C Proye; B Conte-Devolx; P Chanson; Y Y Shugart; D Goldgar; A Murat; A Calender
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

8.  Resistance-promoting effects of ependymoma treatment revealed through genomic analysis of multiple recurrences in a single patient.

Authors:  Christopher A Miller; Sonika Dahiya; Tiandao Li; Robert S Fulton; Matthew D Smyth; Gavin P Dunn; Joshua B Rubin; Elaine R Mardis
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-04-02

9.  Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Marc J Berna; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2013-05       Impact factor: 1.817

Review 10.  Gastrinoma and neurofibromatosis type 2: the first case report and review of the literature.

Authors:  Sara Massironi; Alessandra Zilli; Roberta Elisa Rossi; Federica Cavalcoli; Dario Conte; Maddalena Peracchi
Journal:  BMC Gastroenterol       Date:  2014-06-24       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.